A Study to Assess Adverse Events and Effectiveness of Injected JUVÉDERM® VOLITE™ Gel Filler for Change in Neck Lines in Adult Chinese Participants

Inclusion Criteria: * Participants in general good health as determined by Treating Investigator's (TI) judgment, including no known active pandemic infection. * Participants seeking improvement of transverse neck lines and hydration in neck area. * Has moderate or severe transverse neck lines (ATNLS Grade 2 or 3) on EI live assessment. * The participant is able to achieve at least a 1-point improvement in Allergan Transverse Neck Lines Scale (ATNLS) score with the allowed injection volume in the judgment of TI. Exclusion Criteria: * Neck deformity or significant skin laxity with severe redundant folds. * History of anaphylaxis or allergy to lidocaine (or any amide-based anesthetics), HA (hyaluronic acid) products, or Streptococcal protein, or is planning to undergo desensitization therapy during the study. * Have a history of or currently suffer from autoimmune disease (e.g., rheumatoid arthritis, Crohn's disease). * Current cutaneous inflammatory or infectious processes (e.g., acne, herpes, dermatitis), abscess, an unhealed wound, or a cancerous or precancerous lesion on skin of the neck. * History of thyroid cancer, thyroid-related diseases, skin cancer of the neck, radiation of the treatment area, or de novo cancer in the treatment area. * Tendency to develop hypertrophic scarring. * Has ever received permanent soft tissue fillers (e.g., polymethylmethacrylate, silicone, polytetrafluoroethylene), calcium hydroxyapatite filler, or autologous fat in the neck area. * Has undergone neck surgery. * Semi-permanent soft tissue fillers (e.g., poly-L-lactic acid, polycaprolactone) in the neck area within 2 years before enrollment. * Botulinum toxin in the neck area within 6 months before enrollment. * Neck tattoos, piercings, pigmentation, hair, or past trauma that would interfere with the visualization of the neck area for the effectiveness assessments.